SCHEMBL200660

SCHEMBL200660

O=C1C=C[N]C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoquinone SCHEMBL18103 0.69 — —
Benzoquinone SCHEMBL30679171 0.69 — —
Benzoquinone SCHEMBL3208089 0.69 — —
Benzoquinone SCHEMBL460082 0.69 ALDH1A1 (1.00) —
Benzoquinone SCHEMBL5308519 0.69 ALDH1A1 (1.00) —
Benzoquinone SCHEMBL10506648 0.69 ALDH1A1 (1.00) —
Benzoquinone SCHEMBL11216174 0.65 — —
Benzoquinone SCHEMBL7112416 0.65 ALDH1A1 (0.89) —
Benzoquinone SCHEMBL11299551 0.65 ALDH1A1 (0.89) —
Benzoquinone SCHEMBL21494172 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1951 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024067465-A1 KIF18A INHIBITOR 山东轩竹医药科技有限公司 2024-04-04 — — WO claimed
US-20240101576-A1 HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER ANTARES THERAPEUTICS, INC. 2024-03-28 — — US claimed
WO-2024032661-A1 KIF18A INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2024-02-15 — — WO claimed
WO-2024035950-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2024-02-15 — — WO claimed
CN-117355532-A Tri-fused ring USP1 inhibitors and uses thereof 山东轩竹医药科技有限公司 2024-01-05 — — CN claimed
CN-117337290-A Tri-ring ubiquitin-specific protease 1 inhibitors and uses thereof 山东轩竹医药科技有限公司 2024-01-02 — — CN claimed
CN-117024319-A Amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-11-10 — — CN claimed
CN-116981667-A Heterocyclic inhibitors of EGFR and/or HER2 for cancer treatment 蝎子疗法股份有限公司 2023-10-31 — — CN claimed
WO-2023183601-A1 METHODS OF SYNTHESIZING EGFR INHIBITORS SCORPION THERAPEUTICS, INC. (US) 2023-09-28 — — WO claimed
CN-116731022-A Tri-ring ubiquitin-specific protease 1 inhibitors and uses thereof 轩竹生物科技股份有限公司 2023-09-12 — — CN claimed
EP-0350691-A2 Heterocyclically substituted alpha-aryl-acrylic-acid esters, and fungicides containing these compounds BASF Aktiengesellschaft (DE) 1990-01-17 — — EP claimed
WO-1989010925-A1 NOVEL COMPOUNDS AND TREATMENT BEECHAM GROUP PLC (GB) 1989-11-16 — — WO claimed
EP-0064740-B1 CEPHALOSPORIN DERIVATIVES, AND PROCESS FOR THEIR PREPARATION HOECHST AKTIENGESELLSCHAFT (DE) 1986-04-09 — — EP claimed
EP-0034759-B1 CHROMOGEN CEPHALOSPORINS AND PROCESS FOR THEIR PREPARATION HOECHST AKTIENGESELLSCHAFT (DE) 1986-01-02 — — EP claimed
EP-0135142-A2 Cephalosporin derivatives and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1985-03-27 — — EP claimed
US-4448880-A Detection of β-lactamase utilizing a chromophoric cephalosporin composition HOECHST AG. (DE) 1984-05-15 — — US claimed
EP-0088320-A2 Cephalosporin derivatives and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1983-09-14 — — EP claimed
EP-0064740-A2 Cephalosporin derivatives, and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1982-11-17 — — EP claimed
US-4353824-A DETECTORS OF BETA-LACTAMASES HOECHST AKTIENGESELLSCHAFT (DE) 1982-10-12 — — US claimed
US-4312873-A FUNGICIDES SYNTEX (U.S.A.) INC. (US) 1982-01-26 — — US claimed
Send feedback